Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Miyuki Matsukawa"'
Autor:
Takeshi Nakahara, Hiroyuki Murota, Miyuki Matsukawa, Hiroe Takeda, Yilong Zhang, Tomohiro Kondo
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 10, Pp 2905-2916 (2024)
Abstract Background Atopic dermatitis (AD) is a chronic condition with an increasing incidence in Japan. Difamilast and delgocitinib are both new topical drugs for AD proven to be efficacious and safe in phases 2 and 3 clinical trials in Japan. Howev
Externí odkaz:
https://doaj.org/article/1bd9952dbcbb4c4ea297268b5d5b1a3b
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
ObjectiveThis study aimed to describe the migraine burden and healthcare utilization in the context of headache frequency using nationwide claims data linked to online survey data previously collected in Japan.BackgroundIt has been shown that increas
Externí odkaz:
https://doaj.org/article/5ea0677abc8245cfb1882c9da8a13d89
Publikováno v:
Endocrine Journal, Vol 70, Iss 12, Pp 1195-1205 (2023)
We aimed to survey the status of tolvaptan administration in routine clinical practice since the approval of a novel indication for treating syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in Japan. Data from a population of 3,152
Externí odkaz:
https://doaj.org/article/9b9939d10dd6443290df6890d16e470e
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-12 (2019)
Abstract Background Infliximab, an anti-tumor necrosis factor-alpha antibody, has been reported to have excellent efficacy for refractory uveoretinitis in Behçet’s disease (RUBD), and was approved for this indication in Japan. However, the long-te
Externí odkaz:
https://doaj.org/article/c827df95bea947888cf293f8067d6faa
Publikováno v:
Circulation Reports. 5:27-37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e5af6b4311380bd0868c9531c88c1d5
https://doi.org/10.1253/circrep.cr-22-0091
https://doi.org/10.1253/circrep.cr-22-0091
Publikováno v:
Journal of cardiology.
The impact of tolvaptan on the long-term outcomes of patients with heart failure (HF) remains inconclusive. We evaluated patients requiring long-term congestion management for the time to rehospitalization for HF (HF rehospitalization), the time to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b09928ef6b5b830a162331b391c55f66
https://pubmed.ncbi.nlm.nih.gov/36587792
https://pubmed.ncbi.nlm.nih.gov/36587792
Publikováno v:
Advances in therapyReferences. 39(9)
Treatment continuation is essential for relapse prevention in patients with schizophrenia. The aim of this exploratory study was to compare the time to treatment discontinuation between patients with schizophrenia prescribed brexpiprazole (BRX group)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef2063ef7f5e60bc1dacb9112287106a
https://pubmed.ncbi.nlm.nih.gov/35904721
https://pubmed.ncbi.nlm.nih.gov/35904721
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Maki Gouda,1 Miyuki Matsukawa,2 Hiroaki Iijima3 1Medical Intelligence Department, Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan; 2Data Science Department, Ikuyaku. Integrated Value Development Divi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4c33a3614904901d03c72b5209bca82
http://europepmc.org/articles/PMC6199223
http://europepmc.org/articles/PMC6199223
Autor:
Hajime Kubo, Tohru Kobayashi, Naomi Iwata, Noriko Sato, Toru Igarashi, Hiromichi Hamada, Miyuki Matsukawa, Syuji Takei, Masaru Miura, Yoshifumi Sasaki
Publikováno v:
The Pediatric infectious disease journal. 39(1)
Background In 2015, infliximab was approved for the treatment of patients with intravenous immunoglobulin-refractory Kawasaki disease (KD) in Japan. However, limited real-world data exist on the usefulness of infliximab for acute KD patients. We cond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9815337a66e56a375e8d6a17db69c4d1
https://pubmed.ncbi.nlm.nih.gov/32251260
https://pubmed.ncbi.nlm.nih.gov/32251260
Autor:
Hiroshi Ito, Takashi Kadowaki, Kazuyo Sasaki, Sonoe Hiraide, Masakazu Haneda, Makoto Ueno, Miyuki Matsukawa
Publikováno v:
Advances in Therapy
Introduction Healthy eating is a critical aspect of the prevention and management of type 2 diabetes (T2DM). Disrupted eating patterns can result in poor glucose control and increase the likelihood of diabetic complications. Teneligliptin inhibits di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a0a004b6e917a1f61555704cfd6de55
http://europepmc.org/articles/PMC6015125
http://europepmc.org/articles/PMC6015125